Rogers Corp. Dl 1 Aktie
Finanztrends
Rogers Corp. Dl 1 Aktie
Heute muss Rogers Corp. Dl 1 einen kleinen Kursanstieg von 0,95 % verzeichnen.
Die Community sieht die Rogers Corp. Dl 1 Aktie durchweg positiv, wobei besonders das Kriterium Zyklische Abhängigkeiten hervorgehoben wird.
Was spricht für und gegen Rogers Corp. Dl 1 in den nächsten Jahren?
Pro
?
M************
?
U****************
?
W******* i* V********
Kontra
?
M****
?
A****************
?
L*********** I********** f** d** n******* J****
Sag auch du wie 3 andere deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Rogers Corp. Dl 1 im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Rogers Corp. Dl 1 | 0,95 % | -15,97 % | -29,58 % | 75,44 % | 26,58 % | -33,77 % | -42,20 % |
| Universal Display Corp. | 0,69 % | -0,11 % | -8,02 % | -45,68 % | -31,51 % | -46,53 % | -64,71 % |
| Vishay Intertechnology Inc. | 4,81 % | -18,34 % | -37,74 % | 98,38 % | 131,35 % | 16,27 % | 57,53 % |
| Silicon Labs Inc. | 0,00 % | 0,00 % | -1,59 % | 58,97 % | 67,57 % | 40,91 % | 55,00 % |
Kommentare
News
Avalyn Pharma Outlines Inhaled Fibrosis Push After IPO, With Pivotal Data Ahead
Key Points
- Interested in Avalyn Pharma Inc.? Here are five stocks we like better.
- Avalyn Pharma is pursuing inhaled versions of approved pulmonary fibrosis drugs to reduce side effects that
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It
Roger E. Susi, CEO, President, and Chairman of IRADIMED CORPORATION (NASDAQ:IRMD), reported the indirect sale of 7,500 shares of common stock across multiple open-market transactions on May 26, 2026
Iradimed’s CEO and Founder Sold 7,500 Company Shares. What Does That Mean for Investors?
Roger E. Susi, Founder, CEO, President, and Chairman of Iradimed Corporation (NASDAQ:IRMD), reported the indirect sale of 7,500 shares of common stock over multiple transactions on May 18 and May